Le Lézard
Classified in: Covid-19 virus
Subject: AVO

Esqyr Urges State Authorities to Cancel Future In-Person Bar Exams to Prevent Sickness, Ensure Healthy Legal Profession


MINNEAPOLIS, Sept. 16, 2020 /PRNewswire/ -- Esqyr, SBC, the only public benefit company focused on online test preparation, is urging state bar exam authorities to cancel all future in-person bar exams until the Covid-19 pandemic is over.

"Law students shouldn't be forced to choose between their lives or their livelihoods," Esqyr's President Chris Henjum said. "Some states have made the right choice, but far too many have made the sickening decision to potentially prolong this historic public health crisis by offering in-person exams."

The global pandemic recently upended bar exams across the country. Some states have opted to prioritize their students' health by pursuing alternatives to in-person exams, such as online exams, supervised practice, or diploma privilege.

However, other states forged ahead with dangerous in-person exams or delayed in-person test dates. This has led to increased student debt as some law students put their careers on hold waiting for postponed exams or avoiding in-person exams altogether.

"As a company that funds efforts to tackle the student debt crisis, Esqyr has seen the financial impacts of unpredictable in-person exams," Henjum said. "Given available alternatives, state authorities need to immediately cancel all future in-person exams until this pandemic is over."

Esqyr, based in Minneapolis, is the only public benefit corporation focused on online test preparation and donates at least 20% of its profits to tackle the student debt crisis. Esqyr offers affordable bar exam study tools for schools and students. Learn more at esqyr.com and follow Esqyr on Facebook, Twitter, and LinkedIn.

Contact:   

Chris Henjum


President


6127093538


[email protected]

 

SOURCE Esqyr


These press releases may also interest you

at 08:09
Adyton Resources Corporation announces that it has filed its financial statements for the three and twelve months ended December 31, 2023 and accompanying Management Discussion and Analysis on its SEDAR profile at www.sedar.com. ...

at 08:05
Gilead Sciences, Inc. today announced the U.S. Food and Drug Administration (FDA) approved an updated label with additional data reinforcing the safety and efficacy profile of Biktarvy® (bictegravir 50 mg/emtricitabine 200 mg/tenofovir alafenamide...

at 08:00
The "Global Men's Health and Wellness Market: Analysis By Type, By Distribution Channel, By Region Size & Forecast with Impact Analysis of COVID-19 and Forecast up to 2029" report has been added to ResearchAndMarkets.com's offering. In 2023, the...

at 08:00
Citius Pharmaceuticals Inc. ("Citius" or the "Company"), a late-stage biopharmaceutical company dedicated to the development and commercialization of first-in-class critical care products, today announced that it has entered into definitive...

at 07:40
The "Global Weight Loss Drugs Market: Analysis By Product Type, By Drug Type, By Distribution Channel, By End User, By Region, Size and Trends with Impact of COVID-19 and Forecast up to 2029" report has been added to ResearchAndMarkets.com's...

at 07:40
NuRAN Wireless Inc. ("NuRAN" or the "Company") , a leading supplier of mobile and broadband wireless infrastructure solutions, is pleased to announce the execution of a two-year term loan facility agreement (the "Loan...



News published on and distributed by: